These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 21956115)
21. Regulation of the equilibrium between G-quadruplex and duplex DNA in promoter of human c-myc oncogene by a pyrene derivative. Zhang Z; He X; Yuan G Int J Biol Macromol; 2011 Dec; 49(5):1173-6. PubMed ID: 21683090 [TBL] [Abstract][Full Text] [Related]
22. Demonstration of a potent RET transcriptional inhibitor for the treatment of medullary thyroid carcinoma based on an ellipticine derivative. Kumarasamy VM; Sun D Int J Oncol; 2017 Jul; 51(1):145-157. PubMed ID: 28498409 [TBL] [Abstract][Full Text] [Related]
23. Spontaneous DNA lesions modulate DNA structural transitions occurring at nuclease hypersensitive element III(1) of the human c-myc proto-oncogene. Beckett J; Burns J; Broxson C; Tornaletti S Biochemistry; 2012 Jul; 51(26):5257-68. PubMed ID: 22667821 [TBL] [Abstract][Full Text] [Related]
24. Specific stabilization of promoter G-Quadruplex DNA by 2,6-disubstituted amidoanthracene-9,10-dione based dimeric distamycin analogues and their selective cancer cell cytotoxicity. Roy S; Ali A; Kamra M; Muniyappa K; Bhattacharya S Eur J Med Chem; 2020 Jun; 195():112202. PubMed ID: 32302880 [TBL] [Abstract][Full Text] [Related]
25. Thermodynamic stability and folding kinetics of the major G-quadruplex and its loop isomers formed in the nuclease hypersensitive element in the human c-Myc promoter: effect of loops and flanking segments on the stability of parallel-stranded intramolecular G-quadruplexes. Hatzakis E; Okamoto K; Yang D Biochemistry; 2010 Nov; 49(43):9152-60. PubMed ID: 20849082 [TBL] [Abstract][Full Text] [Related]
26. New Dibenzoquinoxalines Inhibit Triple-Negative Breast Cancer Growth by Dual Targeting of Topoisomerase 1 and the Hu MH; Lin JH J Med Chem; 2021 May; 64(10):6720-6729. PubMed ID: 33961424 [TBL] [Abstract][Full Text] [Related]
27. Identification of G-Quadruplex-Binding Inhibitors of Myc Expression through Affinity Selection-Mass Spectrometry. Flusberg DA; Rizvi NF; Kutilek V; Andrews C; Saradjian P; Chamberlin C; Curran P; Swalm B; Kattar S; Smith GF; Dandliker P; Nickbarg EB; O'Neil J SLAS Discov; 2019 Feb; 24(2):142-157. PubMed ID: 30204533 [TBL] [Abstract][Full Text] [Related]
28. The flanking sequence contributes to the immobilisation of spermine at the G-quadruplex in the NHE (nuclease hypersensitivity element) III1 of the c-Myc promoter. Keniry MA; Owen EA FEBS Lett; 2014 May; 588(10):1949-54. PubMed ID: 24735723 [TBL] [Abstract][Full Text] [Related]
29. New Disubstituted Quindoline Derivatives Inhibiting Burkitt's Lymphoma Cell Proliferation by Impeding c-MYC Transcription. Liu HY; Chen AC; Yin QK; Li Z; Huang SM; Du G; He JH; Zan LP; Wang SK; Xu YH; Tan JH; Ou TM; Li D; Gu LQ; Huang ZS J Med Chem; 2017 Jul; 60(13):5438-5454. PubMed ID: 28603988 [TBL] [Abstract][Full Text] [Related]
30. Inducement of G-quadruplex DNA forming and down-regulation of oncogene c-myc by bile acid-amino acid conjugate-BAA. Tian M; Zhang X; Li Y; Ju Y; Xiang J; Zhao C; Tang Y Nucleosides Nucleotides Nucleic Acids; 2010 Mar; 29(3):190-9. PubMed ID: 20408050 [TBL] [Abstract][Full Text] [Related]
31. Targeting Canine Zorzan E; Da Ros S; Giantin M; Shahidian LZ; Guerra G; Palumbo M; Sissi C; Dacasto M J Pharmacol Exp Ther; 2018 Dec; 367(3):461-472. PubMed ID: 30275152 [TBL] [Abstract][Full Text] [Related]
32. Effects of triethylene tetraamine on the G-quadruplex structure in the human c-myc promoter. Yin F; Liu J; Deng X; Wang J J Biochem; 2007 May; 141(5):669-74. PubMed ID: 17339229 [TBL] [Abstract][Full Text] [Related]
33. APTO-253 Stabilizes G-quadruplex DNA, Inhibits MYC Expression, and Induces DNA Damage in Acute Myeloid Leukemia Cells. Local A; Zhang H; Benbatoul KD; Folger P; Sheng X; Tsai CY; Howell SB; Rice WG Mol Cancer Ther; 2018 Jun; 17(6):1177-1186. PubMed ID: 29626127 [TBL] [Abstract][Full Text] [Related]
34. Discovery of a Family of Genomic Sequences Which Interact Specifically with the c-MYC Promoter to Regulate c-MYC Expression. Rezzoug F; Thomas SD; Rouchka EC; Miller DM PLoS One; 2016; 11(8):e0161588. PubMed ID: 27551915 [TBL] [Abstract][Full Text] [Related]
35. Indenoisoquinoline Topoisomerase Inhibitors Strongly Bind and Stabilize the Wang KB; Elsayed MSA; Wu G; Deng N; Cushman M; Yang D J Am Chem Soc; 2019 Jul; 141(28):11059-11070. PubMed ID: 31283877 [No Abstract] [Full Text] [Related]
36. Metastases suppressor NM23-H2 interaction with G-quadruplex DNA within c-MYC promoter nuclease hypersensitive element induces c-MYC expression. Thakur RK; Kumar P; Halder K; Verma A; Kar A; Parent JL; Basundra R; Kumar A; Chowdhury S Nucleic Acids Res; 2009 Jan; 37(1):172-83. PubMed ID: 19033359 [TBL] [Abstract][Full Text] [Related]
37. Structure-based optimization of FDA-approved drug methylene blue as a c-myc G-quadruplex DNA stabilizer. Chan DS; Yang H; Kwan MH; Cheng Z; Lee P; Bai LP; Jiang ZH; Wong CY; Fong WF; Leung CH; Ma DL Biochimie; 2011 Jun; 93(6):1055-64. PubMed ID: 21377506 [TBL] [Abstract][Full Text] [Related]
38. New substituted quinoxalines inhibit triple-negative breast cancer by specifically downregulating the c-MYC transcription. Hu MH; Wu TY; Huang Q; Jin G Nucleic Acids Res; 2019 Nov; 47(20):10529-10542. PubMed ID: 31584090 [TBL] [Abstract][Full Text] [Related]
39. Solution structure of a 2:1 quindoline-c-MYC G-quadruplex: insights into G-quadruplex-interactive small molecule drug design. Dai J; Carver M; Hurley LH; Yang D J Am Chem Soc; 2011 Nov; 133(44):17673-80. PubMed ID: 21967482 [TBL] [Abstract][Full Text] [Related]